Amid layoffs and a disintegrating share price, former investor darling Ginkgo Bioworks is trying out a new tack to find ...

WASHINGTON — Sen. Bill Cassidy (La.), a key Republican senator with seats on the chamber’s health and finance committees, ...

A House committee on Wednesday passed a bill to renew a program aimed at aiding development of drugs for rare diseases in ...

FDA cites Granules, a large Indian generic drug manufacturer, for tossing truckloads of important documents from a facility ...

STAT's podcast The Readout LOUD this week discusses cannabinoid receptor drugs in weight loss, what the Fed's rates cut might ...

A Senate committee voted to hold Ralph de la Torre, CEO of troubled Steward Health Care, in contempt. If the full Senate ...

As for Amazon, it’s staying true to it’s legacy as an online store. Invitations described the event as an opportunity to ...

The program gives manufacturers better access to regulators and the ability to design more flexible clinical trials.

The Federal Reserve yesterday cut interest rates by 50 basis points, in its first time cutting rates in four years. And how ...

GLP-1 based drugs are transforming the treatment of obesity and opening up new avenues for addressing heart disease, ...

Listen: BioMarin’s executive shakeup, a GLP-1 lowers diabetes risk, and a deep look at Recursion’s AI bona fides ...

Serial biotech founder George Church has a new startup, and this time, he has skin in the game, quite literally.